Drotrecogin alfa

N/A

Report date: 2022/01/14 13:23:58
First In Class

Base Information

Drug NameDrotrecogin alfa
Drug Alias NameDrotrecogin alpha卓曲可近αdrotrecogina alfadrotrecoginum alfaZovant +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProtein C replacementsCoagulation factor VIII inhibitorsFactor Va inhibitors
TargetsCoagulation factor VCoagulation factor VIII
Therapy Area/IndicationsMultiple Organ FailureHypotensionRespiratory Distress Syndrome, Adult +[4] 
Global Approved IndicationsMultiple Organ FailureSepsis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2001/11/21
Country/TerritoryCzechiaBelgiumCanada +[27] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California San FranciscoEli Lilly And CompanyEli Lilly Nederland BV
Active IndicationsN/A
Inactive IndicationsMultiple Organ FailureHypotensionRespiratory Distress Syndrome, Adult +[4] 

Other Information

ATC CodeB01AD10
Related LinksWikipediaDrugBankKEGG